Nuvalent Inc Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NUVL | KRYS | ACLX | ||
| Company | Nuvalent Inc Cl A | Krystal Biotech Inc | Arcellx Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 99.48 | 251.78 | 114.40 | ||
| High | 100.86 | 255.05 | 114.54 | ||
| Low | 98.01 | 246.00 | 114.35 | ||
| Latest | 99.53 | 250.16 | 114.51 | ||
| Change | +1.60 | +2.90 | +0.12 | ||
| % Change | +1.63% | +1.17% | +0.10% | ||
| Volume | 520,200 | 188,000 | 752,600 | ||
| 20-Day Average Volume | 529,765 | 305,910 | 4,676,125 | ||
| Previous Close | 97.93 | 247.26 | 114.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 101.57 | 264.33 | 104.82 | ||
| 20-Day Raw Stochastic | 30.05% | 10.52% | 99.44% | ||
| 20-Day Relative Strength | 46.40 | 43.75 | 79.45 | ||
| Weighted Alpha | +28.37 | +47.39 | +13.49 | ||
| Today's Opinion | 8% Buy | 40% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 64% Buy | 80% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.73% since 03/09/26 | -3.28% since 03/09/26 | +0.01% since 03/09/26 | ||
| Low | 96.06 on 03/13/26 | 244.50 on 03/12/26 | 114.23 on 03/10/26 | ||
| High | 103.85 on 03/10/26 | 265.65 on 03/10/26 | 114.54 on 03/16/26 | ||
| 1-Month | |||||
| %Chg | -1.28% since 02/13/26 | -9.51% since 02/13/26 | +67.17% since 02/13/26 | ||
| Low | 96.06 on 03/13/26 | 244.50 on 03/12/26 | 63.15 on 02/20/26 | ||
| High | 107.59 on 02/25/26 | 298.30 on 02/17/26 | 114.80 on 03/06/26 | ||
| 3-Month | |||||
| %Chg | -3.03% since 12/16/25 | +4.87% since 12/16/25 | +72.64% since 12/16/25 | ||
| Low | 95.50 on 01/05/26 | 231.68 on 12/18/25 | 60.35 on 01/05/26 | ||
| High | 113.01 on 01/22/26 | 298.30 on 02/17/26 | 114.80 on 03/06/26 | ||
| 6-Month | |||||
| %Chg | +27.06% since 09/16/25 | +62.04% since 09/16/25 | +48.04% since 09/16/25 | ||
| Low | 75.20 on 09/22/25 | 153.20 on 09/17/25 | 60.35 on 01/05/26 | ||
| High | 113.01 on 01/22/26 | 298.30 on 02/17/26 | 114.80 on 03/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,120,197 | 7,227,905 | 6,689,526 | ||
| Shares Outstanding, K | 72,707 | 29,232 | 58,480 | ||
| Annual Sales | 0 | 389,130,000 | 22,290,000 | ||
| Annual Net Income | -425,380,000 | 204,830,000 | -228,930,000 | ||
| Last Quarter Sales | 0 | 107,110,000 | 1,650,000 | ||
| Last Quarter Net Income | -118,710,000 | 51,400,000 | -58,110,000 | ||
| 60-Month Beta | 1.32 | 0.49 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.58 on 02/26/26 | 1.70 on 02/17/26 | -0.99 on 11/05/25 | ||
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.10 | 0.00 | ||